Carter-Wallace Wampole Diagnostics Unit Being Acquired By Private Group
This article was originally published in The Gray Sheet
Executive Summary
Carter-Wallace's $50 mil. Wampole Labs diagnostics business will be purchased by MedPointe Capital Partners as part of an acquisition that also includes the company's $200 mil. Wallace Labs prescription drug unit.